Regulus

Regulus cues up $100m placement on ADPKD drug data
Pharmaphorum
Tue, 03/12/24 - 11:10 am
Regulus
ADPKD
RGLS8429
microRNA
Regulus reports positive findings from Phase I kidney disease trial
Clinical Trials Arena
Tue, 09/13/22 - 10:36 am
Regulus
kidney disease
RGLS8429
clinical trials
Sanofi walks away from kidney disease therapy, leaving $25M in milestones out of reach for Regulus
Fierce Biotech
Tue, 07/19/22 - 10:21 am
Sanofi
kidney disease
Regulus
lademirsen
Regulus lays off 60% of staff, halts development
Biopharma Dive
Fri, 07/6/18 - 12:18 pm
Regulus
layoffs
restructuring
RG-012
Sanofi Genzyme
Regulus reports a trio of pipeline setbacks
BioPharma Dive
Tue, 06/13/17 - 12:00 pm
Regulus
RG-101
RGLS5040
RG-105
cholestatic disease
type 2 diabetes
hepatitis C
Regulus Dumps Two Drugs, AstraZeneca Sends Back Another, Shares Fall
Xconomy
Mon, 06/12/17 - 10:08 pm
Regulus
AstraZeneca
Regulus Hep C Drug Stays On Clinical Hold
Investopedia
Wed, 02/1/17 - 09:37 am
Regulus
hepatitis C
RG-101
Regulus hits further setbacks as clinical hold upheld
BioPharma Dive
Mon, 01/30/17 - 11:40 am
Regulus
clinical trials
RG-101
hepatitis C
FDA halts testing of Regulus' Hep C drug, sending shares into tailspin
BioPharma Dive
Tue, 06/28/16 - 11:04 am
FDA
Regulus
hepatitis C
clinical trials
RG-101
The Top 4 Biopharma Movers of the Past Week
24/7 Wall St
Sun, 02/21/16 - 11:39 am
Ocular Therapeutix
Regulus
Zafgen
Aerie Pharma
Should Gilead Investors Fear Regulus?
Seeking Alpha
Thu, 02/18/16 - 09:37 am
Gilead Sciences
Regulus
hepatitis C
Harvoni
RG-101
Regulus Bolsters Argument for Effective Hepatitis C Injection
TheStreet.com
Wed, 02/17/16 - 11:36 am
Regulus
hepatitis C
RG-101
3 Key FDA Decisions Expected in February
24/7 Wall St
Sun, 01/31/16 - 01:38 pm
FDA
Vertex Pharmaceuticals
Kalydeco
Regulus
RG-101
Sarepta Therapeutics
eteplirsen
Regulus tanks on CEO's exit as investors fear a bad omen
Fierce Biotech
Tue, 06/2/15 - 04:56 pm
Regulus
[video]2 Small Biotech Stocks Dreaming Big in Hepatitis C
Motley Fool
Mon, 02/16/15 - 10:15 am
hepatitis C
Regulus
Achillion
Regulus slides after hep C contender's results underwhelm investors
Fierce Biotech
Mon, 02/9/15 - 08:30 am
Regulus
hepatitis C
RG-101
microRNA
How 1 Tiny Hepatitis C Drug Developer Trounced Gilead Sciences, Inc. in 2014
Motley Fool
Fri, 01/2/15 - 08:26 am
hepatitis C
Gilead Sciences
Regulus
Harvoni
Sovaldi
RG-101
Regulus Therapeutics more than doubles on early data for microRNA treatment for hepatitis C
Yahoo/AP
Wed, 10/22/14 - 07:05 pm
Regulus
hepatitis C
microRNA
RG-101
Which Companies Are In Michael King's Oncology Wheelhouse?
Seeking Alpha
Sat, 01/12/13 - 10:44 am
Alnylam
Regulus
Isis Pharmaceuticals
SynaGeva BioPharma
Sarepta Therapeutics
Onyx
Celgene
Millennium
Takeda
Ariad Pharmaceuticals
Pharmacyclics
Astex
Regulus Therapeutics: Serious Red Flags At This Public Offering
Seeking Alpha
Mon, 10/8/12 - 10:41 am
Regulus
stock offering
Sanofi
GSK
AstraZeneca

Pages